Correlated Drug Terms (1)

---

	Name (Synonyms)	Correlation
drug1774	Patient sampling Wiki	1.00

Correlated MeSH Terms (2)

---

	Name (Synonyms)	Correlation
D045169	Severe Acute Respiratory Syndrome NIH	0.05
D018352	Coronavirus Infections NIH	0.04

Correlated HPO Terms (0)

---

	Name (Synonyms)	Correlation

Primary Outcomes

Description: Simple and corrected estimate of the number of seropositive individuals/number of individuals at risk in different strata, based on weighting and calibration and taking into account the random cohort effect.

Measure: Cumulative incidence of SARS-Cov2 infection in the general population.

Time: 8 months

---

Secondary Outcomes

Description: Decay kinetics estimated by mixed effect model with repeated data per subject

Measure: Maintenance over time of the acquisition of anti-SARS-Cov2 antibodies

Time: 8 months

---

Description: Rate of use of care (medical care, hospitalization, center 15) linked to the occurrence of symptoms suggestive of a SARS-Cov2 infection, and share attributable to the infection during a time frame of 8 months

Measure: Rate of use of care (medical care, hospitalization, center 15) linked to the occurrence of symptoms suggestive of a SARS-Cov2 infection, and share attributable to the infection

Time: 8 months

---

Description: Proportion of infections without reported or pauci-symptomatic symptoms and their epidemiological and social déterminants during a time frame of 8 months.

Measure: Proportion of infections without reported or pauci-symptomatic symptoms and their epidemiological and social determinants

Time: 8 months

---

Description: Proportion of tests proposed, accepted, performed, based on social and demographic characteristics during a time frame of 8 months.

Measure: Proportion of tests proposed, accepted, performed, based on social and demographic characteristics

Time: 8 months

---

Description: Proportion and intensity of use of barrier measures (hydroalcoholic gel, mask, social distancing, description of outings / reasons, duration, frequency) and association with the level of seroprevalence during a time frame of 8 months

Measure: Proportion and intensity of use of barrier measures (hydroalcoholic gel, mask, social distancing, description of outings / reasons, duration, frequency) and association with the level of seroprevalence

Time: 8 months

---

Description: Strengths of associations between socio-behavioral factors and level of seroprevalence during a time frame of 8 months

Measure: Strengths of associations between socio-behavioral factors and level of seroprevalence

Time: 8 months

---